Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of +5.26% and -70.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is slated to report third-quarter 2025 results on Nov. 5, before the opening bell.

Recursion Pharmaceuticals ( ($RXRX) ) has provided an update. Recursion Pharmaceuticals announced significant leadership changes effective January ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Social media users took the "Scream" trailer to task in the wake of Barrera's removal following pro-Palestinian posts ...

The possibility that our entire universe merely exists inside a computer simulation is more than an idle science fiction ...

It's a plot device beloved by science fiction: our entire universe might be a simulation running on some advanced ...

As the Oregon National Guard lawsuit proceeds, it’s become clear that right-wing content creators have a direct line to the ...

When I introduced Steven Pinker, it felt like our worldviews couldn't have been more different. Here's why that dissonance was exactly the point.

Learn how Claude's ability to monitor its internal states could transform AI safety and provide insights into human brain ...

Bristol Myers Squibb is shedding two clinical programs, one from its 2023 Mirati buyout and another from a partnership with U ...